Abstract
As the epidemic of obesity continues to infest the world population at alarming proportions, researchers have started to focus on the endocrine aspect of its basic unit: the adipocyte. The last two decades have proved beneficial in understanding the impact of adipocytes, specifically the metabolic influences of its hormones, the adipocytokines. This review focuses on our current understanding of leptin and adiponectin, two of the most studied and established adipocytokines. Patents regarding leptin and adiponectin are highlighted.
Keywords: Leptin, adiponectin, patents
Related Journals
Current Diabetes Reviews
Current Medicinal Chemistry
Current Pharmaceutical Design
Current Topics in Medicinal Chemistry
Current Respiratory Medicine Reviews
Infectious Disorders - Drug Targets
Endocrine, Metabolic & Immune Disorders - Drug Targets
Anti-Infective Agents
Coronaviruses
Recent Advances in Inflammation & Allergy Drug Discovery
Related Books
Herbal Medicine for Autoimmune Diseases
The NLRP3 Inflammasome: An Attentive Arbiter of Inflammatory Response
Natural Immunomodulators: Promising Therapy for Disease Management
Herbal Immunity Boosters Against COVID-19
The Role of Nitric Oxide in Type 2 Diabetes
Mitochondrial DNA and the Immuno-inflammatory Response: New Frontiers to Control Specific Microbial Diseases
Pharmacological and Molecular Perspectives on Diabetes
Diabesity: A Multidisciplinary Approach
Frontiers in Clinical Drug Research – Anti Allergy Agents
Frontiers in Clinical Drug Research-Diabetes and Obesity
4